Technology has become a regular part of our everyday lives. Smartphones and other wearable sensors have put touchscreens and high-fidelity sensors into the pockets of billions of people. These technologies provide an opportunity to paint a rich understanding of health and disease in the natural world outside of the clinic. They also provide communication tools that allow participants a more active voice in research programs.
At Sage Bionetworks, we work to advance health research through practices that support the design, development and implementation of studies that use technology to monitor health outside of the clinical setting, and the analysis and sharing of the resulting study data. We help to derive and test digital biomarkers. We evaluate analytical methodologies to benchmark best practices in study design and data analysis. We have worked with:
- Pharmaceutical companies, including partnering with Novartis to study multiple sclerosis, Lilly to study Parkinson’s disease, Celgene to study Asthma, and BioMarin to study PKU.
- Academic partners, including partnering with the NIH to integrate digital health technologies into the All of Us Research program.
- Technology companies, including partnering with Apple to launch the first ResearchKit studies, and Samsung to launch ResearchStack studies.
- A consortium of industry partners to develop open digital biomarkers for psoriasis and psoriatic arthritis